Rein Therapeutics, Inc. (RNTX): Insider Trading, Congress Trades & Research | Tormere

RNTX

$0.70+20.75%visit website download financials (.py)

Rein Therapeutics, Inc.

Market Cap

$60M

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.32

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Price / TTM revenue

P/B

1.1

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

8 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-27	2026-05-28	VON RICKENBACH JOSEF H	Director	Purchase	4,500	$1.07	$5K	62.5K	View
2026-05-26	2026-05-28	VON RICKENBACH JOSEF H	Director	Purchase	23.2K	$1.06	$24K	58.0K	View
2026-05-22	2026-05-28	VON RICKENBACH JOSEF H	Director	Purchase	15.9K	$1.05	$17K	34.8K	View
2026-05-21	2026-05-28	VON RICKENBACH JOSEF H	Director	Purchase	3,420	$1.04	$4K	18.9K	View
2026-04-30	2026-05-13	WINDSOR JAMES BRIAN	Director & See Remarks	Purchase	25.0K	$1.00	$25K	27.0K	View

1–5 of 9

1 / 2

Recent News

Maxim Group Maintains Rein Therapeutics(RNTX.US) With Buy Rating, Maintains Target Price $4

Moomoo · 2026-10-23

Rein Therapeutics (RNTX) Ticks Up 1.37% to $0.80 as Traders Eye Resistance - Single Stock ETF

siam.in · 2026-09-20

We're Hopeful That Rein Therapeutics (NASDAQ:RNTX) Will Use Its Cash Wisely

Simply Wall Street · 2026-09-05

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Yahoo Finance · 2026-09-04

Here's Why You Should Add RNTX Stock to Your Portfolio Now

Yahoo Finance · 2026-09-03

Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis

Yahoo Finance · 2026-08-20

Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-08-14

Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications

Yahoo Finance · 2026-08-04

Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Yahoo Finance · 2026-07-21

RNTX Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy

Yahoo Finance · 2026-06-17

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

Yahoo Finance · 2026-06-11

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

Yahoo Finance · 2026-05-18

RNTX Slides As Rein Therapeutics Stock Tests New Lows

Timothy Sykes · 2026-05-03

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Yahoo Finance · 2026-05-01

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-05-27	VON RICKENBACH JOSEF H	P	4,500	$4,818.6
2026-05-26	VON RICKENBACH JOSEF H	P	23,190	$24,470.09
2026-05-22	VON RICKENBACH JOSEF H	P	15,950	$16,707.63
2026-05-21	VON RICKENBACH JOSEF H	P	3,420	$3,564.32
2026-04-30	WINDSOR JAMES BRIAN	P	25,000	$25,000